

Shaping African
Precision Oncology For a Better Tomorrow
We're building the next generation of liquid biopsy multi-cancer early-detection tests using uniquely African datasets for enhanced precision and reduced clinical bias.
We're building that here, in Africa.
​
From Africa, to the World.
WHY LIQUID BIOPSY?
Liquid biopsy screens provide several advantages over traditional tissue biopsies, most notably it's comparatively low invasiveness.
For patients for which tissue-based testing is not appropriate or available, liquid biopsy can provide a safe alternative for diagnosis.


HOW IT WORKS
01
BLOOD DRAW
A blood sample is all we need to confirm or make a primary diagnosis. No invasive surgeries, no delays.
02
ANALYSIS
We analyse a proprietary list of the most relevant biomarkers through our state of the art machine learning platform.
03
DIAGNOSIS
We provide a report to the primary care physician outlining the primary diagnosis confirmation and cancer type.
Meet the Team
We're on a mission to change the way cancer is diagnosed. Pleased to meet you.
Everyone needs a little advice sometimes...
The first step to knowing everything is knowing that you don't.
Our advisors cover the four pillars of our core business:
Cancer Biology, Bioinformatics, Ethics, and of course Business.